Screening of aptamers specific to colorectal cancer cells and stem cells by utilizing On-chip Cell-SELEX

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Hung, Lien Yu ^a   Wang, Chih Hung ^a   Che, Yu Jui ^a   Fu, Chien Yu ^a   Chang, Hwan You ^a   Wang, Kuan ^b   Lee, Gwo Bin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; SINGLE STRANDED DNA; TUMOR MARKER;

CANCER STEM CELL; CHEMISTRY; COLORECTAL TUMOR; CYTOLOGY; DEVICES; FLOW CYTOMETRY; HUMAN; IMMUNOMAGNETIC SEPARATION; KINETICS; METABOLISM; MICROFLUIDIC ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; SYSTEMATIC EVOLUTION OF LIGANDS BY EXPONENTIAL ENRICHMENT APTAMER TECHNIQUE; TUMOR CELL LINE;

APTAMERS, NUCLEOTIDE; BASE SEQUENCE; BIOMARKERS, TUMOR; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA, SINGLE-STRANDED; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; KINETICS; MICROFLUIDIC ANALYTICAL TECHNIQUES; NEOPLASTIC STEM CELLS; SELEX APTAMER TECHNIQUE;

EID: 84930210023     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10326     Document Type: Article

References (46)

1. Siegel, R., Ma, J. M., Zou, Z. H. & Jemal, A. Cancer Statistics, 2014. Ca-Cancer J. Clin. 64, 9-29, doi:Doi 10.3322/Caac.21208 (2014).
2. Siegel, R., DeSantis, C. & Jemal, A. Colorectal cancer statistics, 2014. Ca-Cancer J Clin. 64, 104-117, doi:Doi 10.3322/Caac.21220 (2014).
3. Levin, B. et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134, 1570-1595, doi:DOI 10.1053/j.gastro.2008.02.002 (2008).
4. Quintero, E. et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. The New England journal of medicine 366, 697-706, doi:10.1056/NEJMoa1108895 (2012).
5. Allison, J. E., Tekawa, I. S., Ransom, L. J. & Adrain, A. L. A comparison of fecal occult-blood tests for colorectal-cancer screening. The New England journal of medicine 334, 155-159, doi:10.1056/NEJM199601183340304 (1996).
6. Forones, N. M. & Tanaka, M. CEA and CA 19-9 as prognostic indexes in colorectal cancer. Hepato-Gastroenterol 46, 905-908 (1999).
7. Al-Shuneigat, J. M., Mahgoub, S. S. & Huq, F. Colorectal carcinoma: nucleosomes, carcinoembryonic antigen and ca 19-9 as apoptotic markers; a comparative study. J. Biomed. Sci. 18, doi:Artn 50, Doi 10.1186/1423-0127-18-50 (2011).
8. Van Cutsem, E. et al. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer. N. Engl. J. Med. 360, 1408-1417, doi:Doi 10.1056/Nejmoa0805019 (2009).
9. Eaves, C. J. CANCER STEM CELLS Here, there, everywhere? Nature 456, 581-582, doi:Doi 10.1038/456581a (2008).
10. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature medicine 3, 730-737, doi:Doi 10.1038/Nm0797-730 (1997).
11. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115, doi:Doi 10.1038/ Nature05384 (2007).
12. Nguyen, L. V., Vanner, R., Dirks, P. & Eaves, C. J. Cancer stem cells: an evolving concept. Nat. Rev. Cancer 12, 133-143, doi:Doi 10.1038/Nrc3184 (2012).
13. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. P. Natl. Acad. Sci. USA 100, 3983-3988, doi:DOI 10.1073/pnas.0530291100 (2003).
14. Reya, T., Morrison, S. J., Clarke, M. F. & Weissman, I. L. Stem cells, cancer, and cancer stem cells. Nature 414, 105-111, doi:Doi 10.1038/35102167 (2001).
15. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003-U1001, doi:Doi 10.1038/Nature06196 (2007).
16. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F. & Kirchner, T. Opinion -Migrating cancer stem cells -an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749, doi:Doi 10.1038/Nrc1694 (2005).
17. Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. P. Natl. Acad. Sci. USA 104, 10158-10163, doi:DOI 10.1073/pnas.0703478104 (2007).
18. Vaiopoulos, A. G., Kostakis, I. D., Koutsilieris, M. & Papavassiliou, A. G. Colorectal Cancer Stem Cells. Stem Cells 30, 363-371, doi:Doi 10.1002/Stem.1031 (2012).
19. Yeung, T. M., Gandhi, S. C., Wilding, J. L., Muschel, R. & Bodmer, W. F. Cancer stem cells from colorectal cancer-derived cell lines. P. Natl. Acad. Sci. USA 107, 3722-3727, doi:DOI 10.1073/pnas.0915135107 (2010).
20. Haraguchi, N. et al. CD133(+ )CD44(+ ) population efficiently enriches colon cancer initiating cells. Ann. Surg. Oncol. 15, 2927-2933, doi:DOI 10.1245/s10434-008-0074-0 (2008).
21. Ishii, H. et al. Characteristics of Colon Cancer-Initiating Cells. Tumor Biol. 29, 68-68 (2008).
22. Jordan, C. T., Guzman, M. L. & Noble, M. Cancer Stem Cells. N. Engl. J. Med. 355, 1253-1261, doi:doi:10.1056/NEJMra061808 (2006).
23. Ailles, L. E. & Weissman, I. L. Cancer stem cells in solid tumors. Curr. Opin. Biotech. 18, 460-466, doi:DOI 10.1016/j. copbio.2007.10.007 (2007).
24. Magee, J. A., Piskounova, E. & Morrison, S. J. Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty. Cancer Cell 21, 283-296, doi:DOI 10.1016/j.ccr.2012.03.003 (2012).
25. Tuerk, C. & Gold, L. Systematic Evolution of Ligands by Exponential Enrichment -Rna Ligands to Bacteriophage-T4 DNAPolymerase. Science 249, 505-510, doi:DOI 10.1126/science.2200121 (1990).
26. Mendonsa, S. D. & Bowser, M. T. In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis. Anal. Chem. 76, 5387-5392, doi:Doi 10.1021/Ac049857v (2004).
27. Sefah, K., Shangguan, D., Xiong, X. L., O'Donoghue, M. B. & Tan, W. H. Development of DNA aptamers using Cell-SELEX. Nat. Protoc. 5, 1169-1185, doi:DOI 10.1038/nprot.2010.66 (2010).
28. Sefah, K. et al. DNA Aptamers as Molecular Probes for Colorectal Cancer Study. Plos One 5, doi:ARTN e14269, DOI 10.1371/ journal.pone.0014269 (2010).
29. Li, W. M. et al. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells. Biomaterials 35, 6998-7007, doi:DOI 10.1016/j.biomaterials.2014.04.112 (2014).
30. Mosing, R. K., Mendonsa, S. D. & Bowser, M. T. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal. Chem. 77, 6107-6112, doi:Doi 10.1021/Ac050836q (2005).
31. Bowser, M. T., Mendonsa, S. D. & Mosing, R. CE-selex: In vitro selection of DNA APTAMERS using capillary electrophoresis. Abstr. Pap. Am. Chem. S. 229, U139-U139 (2005).
32. Park, S. M. et al. Selection and elution of aptamers using nanoporous sol-gel arrays with integrated microheaters. Lab. on a chip 9, 1206-1212, doi:Doi 10.1039/B814993c (2009).
33. Qian, J. R., Lou, X. H., Zhang, Y. T., Xiao, Y. & Soh, H. T. Generation of Highly Specific Aptamers via Micromagnetic Selection. Anal. Chem. 81, 5490-5495, doi:Doi 10.1021/Ac900759k (2009).
34. Weng, C. H. et al. An automatic microfluidic system for rapid screening of cancer stem-like cell-specific aptamers. Microfluid Nanofluid 14, 753-765, doi:DOI 10.1007/s10404-012-1095-3 (2013).
35. Hung, L. Y., Wang, C. H., Hsu, K. F., Chou, C. Y. & Lee, G. B. An on-chip Cell-SELEX process for automatic selection of highaffinity aptamers specific to different histologically classified ovarian cancer cells. Lab on a chip 14, 4017-4028, doi:Doi 10.1039/ C4lc00587b (2014).
36. Van Simaeys, D. et al. Study of the Molecular Recognition of Aptamers Selected through Ovarian Cancer Cell-SELEX. Plos One 5, doi:ARTN e13770, DOI 10.1371/journal.pone.0013770 (2010).
37. Srivastava, V. K. & Nalbantoglu, J. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stemlike phenotype. Cytom. Part A. 73A, 940-948, doi:Doi 10.1002/Cyto.A.20633 (2008).
38. Wang, P. et al. Identification and Characterization of Cells with Cancer Stem Cell Properties in Human Primary Lung Cancer Cell Lines. Plos One 8, doi:ARTN e57020, DOI 10.1371/journal.pone.0057020 (2013).
39. Wang, J. P. et al. Selection of phage-displayed peptides on live adherent cells in microfluidic channels. P. Natl. Acad. Sci. USA 108, 6909-6914, doi:DOI 10.1073/pnas.1014753108 (2011).
40. Huang, C. J., Lin, H. I., Shiesh, S. C. & Lee, G. B. An integrated microfluidic system for rapid screening of alpha-fetoproteinspecific aptamers. Biosens Bioelectron 35, 50-55, doi:DOI 10.1016/j.bios.2012.02.024 (2012).
41. Weng, C. H., Lien, K. Y., Yang, S. Y. & Lee, G. B. A suction-type, pneumatic microfluidic device for liquid transport and mixing. Microfluid Nanofluid 10, 301-310, doi:DOI 10.1007/s10404-010-0669-1 (2011).
42. Yang, Y. N., Hsiung, S. K. & Lee, G. B. A pneumatic micropump incorporated with a normally closed valve capable of generating a high pumping rate and a high back pressure. Microfluid Nanofluid 6, 823-833, doi:DOI 10.1007/s10404-008-0356-7 (2009).
43. Huang, S. B., Wu, M. H., Cui, Z. F., Cui, Z. & Lee, G. B. A membrane-based serpentine-shape pneumatic micropump with pumping performance modulated by fluidic resistance. J. Micromech. Microeng. 18, doi:Artn 045008, Doi 10.1088/0960-1317/18/4/045008 (2008).
44. Strober, W. Trypan blue exclusion test of cell viability. Current protocols in immunology/edited by John E. Coligan [et al.] Appendix 3, Appendix 3B, doi:10.1002/0471142735.ima03bs21 (2001).
45. Hung, L. Y. et al. An integrated microfluidic platform for rapid tumor cell isolation, counting and molecular diagnosis. Biomed Microdevices 15, 339-352, doi:DOI 10.1007/s10544-013-9739-y (2013).
46. Keefe, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat. Rev. Drug. Discov. 9, 537-550, doi:Doi 10.1038/Nrd3141 (2010).